ARCHIVES

FDA says official spoke on own behalf in admonition to The Cancer Letter. Association of Health Care Journalists asks FDA official to rescind her rebuke.

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | March 18, 2005

Download PDF Visit The Full Archive

Related Articles

HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations

March 2, 2012

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994

In Brief: NCAB Meeting Set For Oct. 3-5; Second Workshop On Tumor Cell Cloning Jan. 3-5

August 24, 1979

More Concept Approvals By DCPC Board

May 18, 1984

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007